Initially, among biomarkers tested, serum SV2A demonstrated the highest diagnostic AUC for identifying aMCI and AD, which was significantly higher than that of NfL (p = 0.0159) and p-tau217 (p = 0.0096) (Additional file 1: Table S2). This evidence concerns the gene SV2A and Alzheimer disease.